Research Article

Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations

Table 1

Baseline characteristics of bAVM patients.

VariablesTotal ()Unruptured ()Ruptured () value

Age, y, mean (SD)29.6 (14.0)31.0 (13.1)28.2 (14.6)0.221
Sex, male (%)79 (55.2)37 (53.6)42 (56.8)0.706
Medical history (%)
 Hypertension9 (6.3)2 (2.9)7 (9.5)0.204
 Diabetes mellitus3 (2.1)1 (1.4)2 (2.7)1.000
 Hyperlipidemia1 (0.7)0 (0)1 (1.4)1.000
 Cigarette smoking26 (18.2)12 (17.4)14 (18.9)0.813
 Alcohol drinking16 (11.2)7 (10.1)9 (12.2)0.702
Prior treatments (%)
 Embolization21 (14.7)7 (10.1)14 (18.9)0.139
 Radiosurgery6 (4.2)1 (1.4)5 (6.8)0.244
 Microsurgery5 (3.5)2 (2.9)3 (4.1)1.000
Primary symptom (%)
 Hemorrhage74 (51.7)0 (0)74 (100.0)<0.001
 Seizure30 (21.0)25 (36.2)5 (6.8)<0.001
 Neurological dysfunction29 (20.3)15 (21.7)14 (18.9)0.675
Admission (%)15 (10.5)1 (1.4)14 (18.9)<0.001
AVM characteristics
 Spetzler-Martin grade (%)0.149
  I-II81 (56.6)34 (49.3)47 (63.5)
  III42 (29.4)22 (31.9)20 (27.0)
  IV-V20 (14.0)13 (18.8)7 (9.5)
 Maximum diameter, cm, median (IQR)3.4 (2.5-4.6)3.9 (3.0-5.1)2.9 (2.3-4.1)<0.001
 Volume, cm3, median (IQR)8.6 (4.4-25.0)15.8 (6.2-33.7)6.0 (3.5-15.3)<0.001
 Deep location (%)33 (23.1)16 (23.2)17 (23.0)0.976
 Eloquent location (%)72 (50.3)34 (49.3)38 (51.4)0.804
 Deep venous drainage (%)43 (30.1)21 (30.4)22 (29.7)0.927
 Associated aneurysms (%)21 (14.7)10 (14.5)11 (14.9)0.950
Clinical features, mean (SD)
 Heart rate, bpm80 (10)80 (9)81 (11)0.405
 SBP, mm Hg120 (15)120 (13)120 (17)1.000
 DBP, mm Hg77 (10)76 (10)78 (11)0.434
 BMI, kg/m222.6 (4.4)23.2 (4.4)22.0 (4.4)0.099
Laboratory results, median (IQR)
 Glucose, mmol/L4.6 (4.3-5.0)4.6 (4.3-4.8)4.6 (4.4-5.1)0.141
 Albumin, g/L43.9 (41.3-46.0)44.4 (41.6-46.1)43.5 (41.0-45.9)0.511
 Creatinine, μmol/L58.6 (46.6-68.5)59.5 (49.7-70.9)56.2 (45.2-67.8)0.109
 UA, μmol/L314.0 (257.7-366.5)324.5 (280.8-374.8)294.0 (241.8-357.1)0.032
 TC, mmol/L4.3 (3.6-4.8)4.3 (3.8-4.9)4.2 (3.5-4.8)0.468
 TG, mmol/L1.0 (0.7-1.5)1.1 (0.8-1.6)0.9 (0.7-1.5)0.130
 HDL-C, mmol/L1.2 (1.0-1.5)1.2 (1.0-1.4)1.2 (1.1-1.5)0.701
 LDL-C, mmol/L2.6 (2.0-3.2)2.8 (2.1-3.5)2.5 (1.9-3.1)0.080
 ApoA, g/L1.3 (1.1-1.4)1.3 (1.1-1.4)1.3 (1.1-1.4)0.588
 ApoB, g/L0.8 (0.7-1.0)0.9 (0.7-1.1)0.8 (0.7-0.9)0.211
 Hcy, μmol/L12.4 (9.9-16.2)13.3 (10.4-18.9)11.7 (9.7-14.6)0.057
 HHcy (%)45 (31.5)28 (40.6)17 (23.0)0.023

bAVM: brain arteriovenous malformation; SD: standard deviation; mRS: modified Rankin Scale; IQR: interquartile range; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; UA: uric acid; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; ApoA: apolipoprotein A; ApoB: apolipoprotein B; Hcy: homocysteine; HHcy: hyperhomocysteinemia. , significant difference.